Science
I Peace announces new iPSC lines to reduce immune rejection risk for U.S. population
More than 100 million people in the US have this HLA-A haplotype PALO ALTO, Calif., Oct. 30, 2024 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://www.ipeace.com), specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived ce
By: en_prnasisa
- Oct 30 2024
- 0
- 0 Views
Share this page
Guest Posts by Easy Branches
